The arrival of Retatrutide ZPHC, at a strength of 120mg, is sparking considerable excitement within the weight loss community. This novel dual GIP and GLP-1 agonist medication appears to offer impressive improvements in fat reduction compared to current therapies. Initial clinical trials have demonstrated marked reductions in body mass , possibly s